Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Lixte Biotechnology Holdings ( (LIXT) ) just unveiled an update.
On May 16, 2025, Lixte Biotechnology Holdings, Inc. received a notice of conversion for its 350,000 shares of Series A Convertible Preferred Stock, which were issued in 2015 and 2016. These shares are convertible into 72,917 shares of common stock, impacting the company’s equity structure and potentially affecting its market positioning.
More about Lixte Biotechnology Holdings
Average Trading Volume: 21,438
Technical Sentiment Signal: Sell
Current Market Cap: $3.49M
For a thorough assessment of LIXT stock, go to TipRanks’ Stock Analysis page.